These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2962590)

  • 1. The effect of foscarnet (phosphonoformate) on human immunodeficiency virus isolation, T-cell subsets and lymphocyte function in AIDS patients.
    Gaub J; Pedersen C; Poulsen AG; Mathiesen LR; Ulrich K; Lindhardt BO; Faber V; Gerstoft J; Hofmann B; Lernestedt JO
    AIDS; 1987 May; 1(1):27-33. PubMed ID: 2962590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphonoformate (foscarnet): a pilot study in AIDS and AIDS related complex.
    Farthing CF; Dalgleish AG; Clark A; McClure M; Chanas A; Gazzard BG
    AIDS; 1987 May; 1(1):21-5. PubMed ID: 2962589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS.
    Jacobson MA; Crowe S; Levy J; Aweeka F; Gambertoglio J; McManus N; Mills J
    J Infect Dis; 1988 Oct; 158(4):862-5. PubMed ID: 2844921
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of cytomegalovirus pneumonitis with foscarnet (trisodium phosphonoformate) in patients with AIDS.
    Farthing C; Anderson MG; Ellis ME; Gazzard BG; Chanas AC
    J Med Virol; 1987 Jun; 22(2):157-62. PubMed ID: 3039052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experiences with phosphonoformate (foscarnet) treatment of viral diseases following renal transplantation.
    Ahlmén J; Wijnween AC; Brynger H; Lycke E
    Scand J Urol Nephrol Suppl; 1985; 92():41-4. PubMed ID: 3008316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute renal failure induced by foscarnet: 4 cases.
    Cacoub P; Deray G; Baumelou A; Le Hoang P; Rozenbaum W; Gentilini M; Soubrie C; Rousselie R; Jacobs C
    Clin Nephrol; 1988 Jun; 29(6):315-8. PubMed ID: 2840226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum HIV antigen and anti-P24-antibodies in 200 HIV seropositive patients: correlation with CD4 and CD8 lymphocyte subsets.
    Andrieu JM; Eme D; Venet A; Audroin C; Tourani JM; Stern M; Israel-Biet D; Beldjord K; Driss F; Even P
    Clin Exp Immunol; 1988 Jul; 73(1):1-5. PubMed ID: 3262463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a 14-day course of foscarnet on cytomegalovirus (CMV) blood markers in a randomized study of human immunodeficiency virus-infected patients with persistent CMV viremia. Agence National de Recherche du SIDA 023 Study Group.
    Salmon-Céron D; Fillet AM; Aboulker JP; Gérard L; Houhou N; Carrière I; Ostinelli J; Vildé JL; Brun-Vézinet F; Leport C
    Clin Infect Dis; 1999 Apr; 28(4):901-5. PubMed ID: 10825058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dose escalation study to determine the toxicity and maximally tolerated dose of foscarnet.
    Seidel EA; Koenig S; Polis MA
    AIDS; 1993 Jul; 7(7):941-5. PubMed ID: 8357555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of foscarnet versus ganciclovir. The Italian Cytomegalovirus Study Group.
    Parente F; Bianchi Porro G
    Am J Gastroenterol; 1998 Mar; 93(3):317-22. PubMed ID: 9517631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foscarnet in the treatment of cytomegalovirus infection of the esophagus and colon in patients with the acquired immune deficiency syndrome.
    Nelson MR; Connolly GM; Hawkins DA; Gazzard BG
    Am J Gastroenterol; 1991 Jul; 86(7):876-81. PubMed ID: 1647659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Declining levels of HIV P24 antigen in serum during treatment with foscarnet.
    Bergdahl S; Sönnerborg A; Larsson A; Strannegard O
    Lancet; 1988 May; 1(8593):1052. PubMed ID: 2896890
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment with trisodium phosphonoformate for primary cytomegalovirus infection after heart transplantation.
    Locke TJ; Odom NJ; Tapson JS; Freeman R; McGregor CG
    J Heart Transplant; 1987; 6(2):120-2. PubMed ID: 3040944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection.
    Carcelain G; Tubiana R; Samri A; Calvez V; Delaugerre C; Agut H; Katlama C; Autran B
    J Virol; 2001 Jan; 75(1):234-41. PubMed ID: 11119593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). An uncontrolled trial.
    Erlich KS; Jacobson MA; Koehler JE; Follansbee SE; Drennan DP; Gooze L; Safrin S; Mills J
    Ann Intern Med; 1989 May; 110(9):710-3. PubMed ID: 2522751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus colitis and oesophageal ulceration in the context of AIDS: clinical manifestations and preliminary report of treatment with Foscarnet (phosphonoformate).
    Weber JN; Thom S; Barrison I; Unwin R; Forster S; Jeffries DJ; Boylston A; Pinching AJ
    Gut; 1987 Apr; 28(4):482-7. PubMed ID: 3034745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular manifestations of HIV infection.
    Jabs DA
    Trans Am Ophthalmol Soc; 1995; 93():623-83. PubMed ID: 8719695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy and immunoprophylaxis of HIV infection].
    Vogt M; Schooley RT; Hirsch MS
    Schweiz Rundsch Med Prax; 1986 Nov; 75(48):1471-5. PubMed ID: 2432642
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial.
    Chaisson RE; Leuther MD; Allain JP; Nusinoff-Lehrman S; Boone GS; Feigal D; Volberding P
    Arch Intern Med; 1988 Oct; 148(10):2151-3. PubMed ID: 3263098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.